Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Differential microRNA expression profile between stimulated PBMCs from HIV-1 infected elite controllers and viremic progressors.

  • Egaña-Gorroño, Lander
  • Escribà, Tuixent
  • Boulanger, Nicolas
  • Guardo, Alberto Crespo
  • León, Agathe
  • Bargalló, Manel Enric
  • García, Felipe
  • Gatell, José María
  • Plana, Montserrat
  • Arnedo, Mireia
  • HIV Controllers Consortium of the AIDS Spanish Network
  • Lopez-Galindez, Luis Cecilio
  • Pernas, Maria
  • Casado, Concepcion
  • Alcamí, José
Background: The emerging relationship between microRNAs (miRNA) and viral-control is a topic of interest in the field of HIV. Host-genome might play an important role in the control of viremia. The aim of this study was to assess the specific miRNA profile that could contribute to the control of HIV replication in Elite Controllers. Results: After adequate normalization, expression profile of 286 human miRNAs (hsa-miR) was evaluated in phytohaemagglutinin-stimulated PBMCs from 29 individuals classified in 4 groups: 8 elite controllers (EC; viral load <50 cp/ml without treatment), 8 viremic progressors (VP; VL>5000 cp/ml without treatment), 8 patients under antiretroviral treatment (ART; VL<200 cp/ml) and 5 uninfected individuals (HIV-) through TaqMan Array Human microRNA Cards v3.0. A differential expression pattern consisting of 23 miRNAs became significantly different when comparing EC and VP. Profiling analysis segregated the population in two different blocks: while EC and HIV- clustered together in the same block (EC/HIV-_block 1), VP and ART individuals clustered together in a second block (VP/ART_block 2). Two inversely expressed miRNA patterns were determined within those two blocks: a set of 4 miRNAs (hsa-miR-221, -27a, -27b and -29b) was up-expressed in EC/HIV-_block and down-expressed in VP/ART_block while 19 miRNAs were down-expressed in block 1 and up-expressed in block 2. Differential miRNAs were successfully validated through individual RT-qPCR assays. Conclusions: Profile in EC resembled HIV- and differentially clusters with VP and ART. Therefore, differential clustering does not rely on undetectable viremia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Gated Mesoporous Silica Nanoparticles Using a Double-Role Circular Peptide for the Controlled and Target-Preferential Release of Doxorubicin in CXCR4-Expresing Lymphoma Cells

  • De La Torre, Cristina
  • Casanova, Isolda
  • Acosta, Gerardo
  • Coll Merino, Mª Carmen
  • Moreno, María José
  • Albericio, Fernando
  • Mangues, Ramón
  • Royo, Miriam
  • Aznar, Elena|||0000-0003-0361-3876
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] B-cell non-Hodgkin s lymphoma (B-NHL) is the most frequent malignant lymphoid neoplasm, which has a high degree of relapse and chemoresist-ance. Thus, strategies to improve currently used therapies are needed. In this context, a new CXCR4-targeted delivery system is described using mesoporous silica nanoparticles (MSNs) that are loaded with doxorubicin and capped with a derivative of the T22 peptide ( P ). This design makes full use of the great affi nity of the T22 peptide to CXCR4 receptor, which is overexpressed in lymphoma cells. The peptide is able to guide the gated nanoparticle to B-NHL cells to facilitate MSNs uptake via the CXCR4 receptor. The endocyted P -capped MSNs are also opened by endosomal proteolytic enzymes to allow intracellular doxorubicin delivery., Financial support from the Spanish Government (MAT2012-38429-C04 and PIB2010BZ-00563), Generalitat Valenciana (PROMETEOII/2014/047), Generalitat de Catalunya (2009-SGR-1437), Instituto de Salud Carlos III (FI10/00758 and FIS PII2/01861), MaratoTV3 416/C/2013-2030, CIBER-BBN (Nanomets), and Institut de Recerca Josep Carreras Sant Pau is gratefully acknowledged. C.T. is grateful to the Spanish MEC for her grant. The authors also acknowledge Cristina Suarez for her technical support and the use of the CIBER-BBN Nanotoxicology and Synthesis of Peptides platforms.
O2, repositorio institucional de la UOC
Publication Artículo científico (JournalArticle)

Personal, indoor and outdoor air pollution levels among pregnant women

  • Schembari, Anna
  • Triguero-Mas, Margarita
  • de Nazelle, Audrey
  • Dadvand, Payam
  • Vrijheid, Martine
  • Cirach, Marta
  • Martinez, David
  • Figueras, Francesc
  • Querol, Xavier
  • Basagaña, Xavier
  • Eeftens, Marloes
  • Meliefste, Kees
  • Nieuwenhuijsen, Mark
Aim The aims of this study were to investigate the relationship between pregnant women's personal exposures to NOx, NO2, PM2.5 concentration and absorbance as a marker for black carbon and their indoor and outdoor concentration levels at their residence, and also to identify predictors of personal exposure and indoor levels using questionnaire and time activity data. Method We recruited 54 pregnant women in Barcelona who carried a personal PM2.5 sampler for two days and NOx/NO2 passive badges for one week, while indoor and outdoor PM2.5 and NOx/NO2 levels at their residence were simultaneously measured. Time activity and house characteristics were recorded. Gravimetry determinations for PM2.5 concentration and absorbance measurements were carried out on the PM2.5 filter samples. Results Levels of personal exposure to NOx, PM2.5 and absorbance were slightly higher than indoor and outdoor levels (geometric mean of personal NOx = 61.9 vs indoor NOx = 60.6 μg m−3), while for NO2 the indoor levels were slightly higher than the personal ones. Generally, there was a high statistically significant correlation between personal exposure and indoor levels (Spearman's r between 0.78 and 0.84). Women spent more than 60% of their time indoors at home. Ventilation of the house by opening the windows, the time spent cooking and indicators for traffic intensity were re-occurring statistically significant determinants of the personal and indoor pollutants levels with models for NOx explaining the 55% and 60% of the variability respectively, and models for NO2 explaining the 39% and 16% of the variability respectively. Models for PM2.5 and absorbance explained the least of the variability. Conclusion Our findings improve the current understanding of the characterization and inter-associations between personal, indoor and outdoor pollution levels among pregnant women. Variability in personal and indoor NOx and to a lesser extent NO2 levels could be explained well, but not the variability in PM2.5 could be explained. Highlights ► First study to report on the personal, indoor and outdoor black carbon levels of pregnant women. ► Time spent indoors by pregnant women does not differ much from that of general population. ► Variability in personal and indoor NOx and NO2 levels could be explained well, but not in PM2.5.
O2, repositorio institucional de la UOC
Publication Artículo científico (JournalArticle)

Source apportionment of indoor, outdoor and personal PM2.5 exposure of pregnant women in Barcelona, Spain

  • Minguillón, María Cruz
  • Schembari, Anna
  • Triguero-Mas, Margarita
  • de Nazelle, Audrey
  • Dadvand, Payam
  • Figueras, Francesc
  • Salvadó, Joan A.
  • Grimalt, Joan O.
  • Nieuwenhuijsen, Mark
  • Querol, Xavier
Exposure to air pollution has been shown to adversely affect foetal development in the case of pregnant women. The present study aims to investigate the PM composition and sources influencing personal exposure of pregnant women in Barcelona. To this end, indoor, outdoor and personal exposure measurements were carried out for a selection of 54 pregnant women between November 2008 and November 2009. PM2.5 samples were collected during two consecutive days and then analysed for black smoke (BS), major and trace elements, and polycyclic aromatic hydrocarbons (PAHs) concentrations. Personal information such as commuting patterns and cosmetics use was also collected. PM2.5 concentrations were higher for personal samples than for indoor and outdoor environments. Indoor, outdoor and personal BS and sulphate concentrations were strongly correlated, although some specific indoor and outdoor sulphate sources may exist. Average trace elements concentrations were similar indoor, outdoor and for personal exposure, but the correlations were moderate for most of them. Most of the PAHs concentrations showed strong correlations indoor–outdoor. A source apportionment analysis of the PM composition data by means of a Positive Matrix Factorization (PMF) resulted in the identification of six sources for the outdoor and indoor environments: secondary sulphate, fueloil + sea salt (characterized by V, Ni, Na and Mg), mineral, cigarette (characterized by K, Ce, Cd, benzo(k)fluoranthene and benzo(ghi)perylene), road traffic (characterized by BS and low weight PAHs), and industrial (characterized by Pb, Sn, Cu, Mn and Fe). For personal exposure two specific sources were found: cosmetics (characterized by abundance of Ca, Li, Ti and Sr and the absence of Al) and train/subway (characterized by Fe, Mn, Cu and Ba). The contribution of the sources varied widely among women, especially for cigarette (from zero to up to 4 μg m−3), train/subway (up to more than 6 μg m−3) and cosmetics (up to more than 5 μg m−3). The source contributions showed generally strong correlations indoor–outdoor although the infiltration efficiencies varied among homes. This study emphasizes the importance of relying on personal exposure in epidemiological studies assessing the impact of air pollution on human health.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Charge effect of a liposomal delivery system encapsulating simvastatin to treat experimental ischemic stroke in rats

  • Campos Martorell, Mireia
  • Cano-Sarabia, Mary|||0000-0003-4254-8157
  • Simats Oriol, Alba|||0000-0002-0415-1135
  • Hernández Guillamón, Maria Mar
  • Rosell Novel, Anna|||0000-0003-1082-3599
  • Maspoch, Daniel|||0000-0003-1325-9161
  • Montaner, Joan|||0000-0003-4845-2279
Although the beneficial effects of statins on stroke have been widely demonstrated both in experimental studies and in clinical trials, the aim of this study is to prepare and characterize a new liposomal delivery system that encapsulates simvastatin to improve its delivery into the brain. In order to select the optimal liposome lipid composition with the highest capacity to reach the brain, male Wistar rats were submitted to sham or transitory middle cerebral arterial occlusion (MCAOt) surgery and treated (intravenous [IV]) with fluorescent-labeled liposomes with different net surface charges. Ninety minutes after the administration of liposomes, the brain, blood, liver, lungs, spleen, and kidneys were evaluated ex vivo using the Xenogen IVIS ® Spectrum imaging system to detect the load of fluorescent liposomes. In a second substudy, simvastatin was assessed upon reaching the brain, comparing free and encapsulated simvastatin (IV) administration. For this purpose, simvastatin levels in brain homogenates from sham or MCAOt rats at 2 hours or 4 hours after receiving the treatment were detected through ultra-high-protein liquid chromatography. Whereas positively charged liposomes were not detected in brain or plasma 90 minutes after their administration, neutral and negatively charged liposomes were able to reach the brain and accumulate specifically in the infarcted area. Moreover, neutral liposomes exhibited higher bioavailability in plasma 4 hours after being administered. The detection of simvastatin by ultra-high-protein liquid chromatography confirmed its ability to cross the blood-brain barrier, when administered either as a free drug or encapsulated into liposomes. This study confirms that liposome charge is critical to promote its accumulation in the brain infarct after MCAOt. Furthermore, simvastatin can be delivered after being encapsulated. Thus, simvastatin encapsulation might be a promising strategy to ensure that the drug reaches the brain, while increasing its bioavailability and reducing possible side effects.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Rat Middle Cerebral Artery Occlusion Is Not a Suitable Model for the Study of Stroke-Induced Spontaneous Infections

  • Campos Martorell, Mireia
  • Hernandez Guillamon, Maria Mar|||0000-0001-8844-0091
  • Rosell Novel, Anna|||0000-0003-1082-3599
  • Gomis Rodríguez, Javier|||0000-0001-6258-3721
  • Salat, David
  • García Bonilla, Lídia|||0000-0003-3832-0037
  • Montaner, Joan|||0000-0003-4845-2279
Infections related to stroke-induced immunodepression are an important complication causing a high rate of death in patients. Several experimental studies in mouse stroke models have described this process but it has never been tested in other species such as rats. Our study focused on the appearance of secondary systemic and pulmonary infections in ischemic rats, comparing with sham and naive animals. For that purpose, male Wistar rats were subjected to embolic middle cerebral artery occlusion (eMCAO) or to transient MCAO (tMCAO) inserting a nylon filament. Forty-eight hours after ischemia, blood and lung samples were evaluated. In eMCAO set, ischemic rats showed a significant decrease in blood-peripheral lymphocytes (naive = 58.8±18.1%, ischemic = 22.9±16.4%) together with an increase in polymorphonuclears (PMNs) (naive = 29.2±14.7%, ischemic = 71.7±19.5%), while no change in monocytes was observed. The increase in PMNs counts was positively correlated with worse neurological outcome 48 hours after eMCAO (r = 0.55, p = 0.043). However, sham animals showed similar changes in peripheral leukocytes as those seen in ischemic rats (lymphocytes: 40.1±19.7%; PMNs: 51.7±19.2%). Analysis of bacteriological lung growth showed clear differences between naive (0±0 CFU/mL; log10) and both sham (3.9±2.5 CFU/mL; log10) and ischemic (4.3±2.9 CFU/mL; log10) groups. Additionally, naive animals presented non-pathological lung histology, while both sham and ischemic showed congestion, edema or hemorrhage. Concordant results were found in the second set of animals submitted to a tMCAO. Inflammatory and infection changes in Wistar rats subjected to MCAO models may be attributed not only to the brain ischemic injury but to the surgical aggression and/or anaesthetic stress. Consequently, we suggest that stroke-induced immunodepression in ischemic experimental models should be interpreted with caution in further experimental and translational studies, at least in rat stroke models that entail cervicotomy and cranial trepanation.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Clinical Features, Neuropsychology and Neuroimaging in Bipolar and Borderline Personality Disorder, A Systematic Review of Cross-Diagnostic Studies

  • Massó Rodriguez, Anna
  • Hogg, Bridget|||0000-0002-2405-0593
  • Gardoki-Souto, Itxaso|||0000-0002-0775-1275
  • Valiente Gomez, Alicia|||0000-0003-0220-2397
  • Trabsa, Amira|||0000-0002-8669-0676
  • Mosquera, Dolores
  • García-Estela, Aitana|||0000-0001-8529-544X
  • Colom, Francesc|||0000-0002-9516-9030
  • Pérez Solà, Víctor|||0000-0002-5825-2337
  • Padberg, Frank|||0000-0001-7638-8310
  • Moreno Alcázar, Ana|||0000-0002-3392-5590
  • Amann, Benedikt L.|||0000-0002-4407-1519
Background: Bipolar Disorder (BD) and Borderline Personality Disorder (BPD) have clinically been evolving as separate disorders, though there is still debate on the nosological valence of both conditions, their interaction in terms of co-morbidity or disorder spectrum and their distinct pathophysiology. Objective: The objective of this review is to summarize evidence regarding clinical features, neuropsychological performance and neuroimaging findings from cross-diagnostic studies comparing BD and BPD, to further caracterize their complex interplay. Methods: Using PubMed, PsycINFO and TripDataBase, we conducted a systematic literature search based on PRISMA guidelines of studies published from January 1980 to September 2019 which directly compared BD and BPD. Results: A total of 28 studies comparing BD and BPD were included: 19 compared clinical features, 6 neuropsychological performance and three neuroimaging abnormalities. Depressive symptoms have an earlier onset in BPD than BD. BD patients present more mixed or manic symptoms, with BD-I differing from BPD in manic phases. BPD patients show more negative attitudes toward others and self, more conflictive interpersonal relationships, and more maladaptive regulation strategies in affective instability with separate pathways. Impulsivity seems more a trait in BPD rather than a state as in BD. Otherwise, BD and BPD overlap in depressive and anxious symptoms, dysphoria, various abnormal temperamental traits, suicidal ideation, and childhood trauma. Both disorders differ and share deficits in neuropsychological and neuroimaging findings. Conclusion: Clinical data provide evidence of overlapping features in both disorders, with most of those shared symptoms being more persistent and intense in BPD. Thus, categorical classifications should be compared to dimensional approaches in transdiagnostic studies investigating BPD features in BD regarding their respective explanatory power for individual trajectories. Systematic Review Registration: The search strategy was pre-registered in PROSPERO: CRD42018100268.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

High incidence of PTSD diagnosis and trauma-related symptoms in a trauma exposed bipolar I and II sample

  • Hogg, Bridget|||0000-0002-2405-0593
  • Valiente Gomez, Alicia|||0000-0003-0220-2397
  • Redolar Ripoll, Diego|||0000-0001-6922-2822
  • Gardoki-Souto, Itxaso|||0000-0002-0775-1275
  • Fontana-McNally, Marta|||0000-0001-6523-6688
  • Lupo, Walter
  • Jiménez, Esther
  • Madre Rull, Mercè|||0000-0002-4660-3216
  • Blanco Presas, Laura|||0000-0001-6272-4416
  • Reinares, María|||0000-0001-8859-4453
  • Cortizo, Romina|||0000-0001-7544-8537
  • Massó Rodriguez, Anna
  • Castaño, Juan
  • Argila-Plaza, Isabel|||0000-0002-1604-4708
  • Castro-Rodríguez, José Ignacio
  • Comes, Mercè
  • Doñate, Marta
  • Herrería, Elvira
  • Macias, Cristina
  • Mur, Estanislao
  • Novo, Patricia
  • Rosa, Adriane R.
  • Vieta, Eduard|||0000-0002-0548-0053
  • Radua, Joaquim|||0000-0003-1240-5438
  • Padberg, Frank|||0000-0001-7638-8310
  • Pérez Solà, Víctor|||0000-0002-5825-2337
  • Moreno Alcázar, Ana|||0000-0002-3392-5590
  • Amann, Benedikt L.|||0000-0002-4407-1519
Post-traumatic stress disorder (PTSD) is an established comorbidity in Bipolar Disorder (BD), but little is known about the characteristics of psychological trauma beyond a PTSD diagnosis and differences in trauma symptoms between BD-I and BD-II. (1) To present characteristics of a trauma-exposed BD sample; (2) to investigate prevalence and trauma symptom profile across BD-I and BD-II; (3) to assess the impact of a lifetime PTSD diagnosis vs. a history of trauma on BD course; and (4) to research the impacts of sexual and physical abuse. This multi-center study comprised 79 adult participants with BD with a history of psychological trauma and reports baseline data from a trial registered in Clinical Trials (; ref: NCT02634372). Clinical variables were gathered through clinical interview, validated scales and a review of case notes. The majority (80.8%) of our sample had experienced a relevant stressful life event prior to onset of BD, over half of our sample 51.9% had a lifetime diagnosis of PTSD according to the Clinician Administered PTSD scale. The mean Impact of Event Scale-Revised scores indicated high levels of trauma-related distress across the sample, including clinical symptoms in the PTSD group and subsyndromal symptoms in the non-PTSD group. Levels of dissociation were not higher than normative values for BD. A PTSD diagnosis (vs. a history of trauma) was associated with psychotic symptoms [2(1) = 5.404, p = 0.02] but not with other indicators of BD clinical severity. There was no significant difference between BD-I and BD-II in terms of lifetime PTSD diagnosis or trauma symptom profile. Sexual abuse significantly predicted rapid cycling [2(1) = 4.15, p = 0.042], while physical abuse was not significantly associated with any clinical indicator of severity. Trauma load in BD is marked with a lack of difference in trauma profile between BD-I and BD-II. Although PTSD and sexual abuse may have a negative impact on BD course, in many indicators of BD severity there is no significant difference between PTSD and subsyndromal trauma symptoms. Our results support further research to clarify the role of subsyndromic PTSD symptoms, and highlight the importance of screening for trauma in BD patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Prevalence and Characterization of Psychological Trauma in Patients with Fibromyalgia, A Cross-Sectional Study

  • Gardoki-Souto, Itxaso|||0000-0002-0775-1275
  • Redolar Ripoll, Diego|||0000-0001-6922-2822
  • Fontana-McNally, Marta|||0000-0001-6523-6688
  • Hogg, Bridget|||0000-0002-2405-0593
  • Castro, María José
  • Blanch Rubió, Josep
  • Ojeda, Fabiola|||0000-0002-6734-9288
  • Solanes, Aleix|||0000-0002-2491-200X
  • Radua, Joaquim|||0000-0003-1240-5438
  • Valiente-Gómez, Alicia|||0000-0003-0220-2397
  • Cirici, Roser|||0000-0001-6878-5631
  • Pérez Solà, Víctor|||0000-0002-5825-2337
  • Amann, Benedikt L|||0000-0002-4407-1519
  • Moreno Alcázar, Ana|||0000-0002-3392-5590
Preliminary evidence suggests that psychological trauma, especially childhood trauma, is a risk factor for the onset of fibromyalgia (FM). The main objective of this study consisted of evaluating the prevalence and detailed characteristics of psychological trauma in a sample of patients with FM, the chronology of trauma across the lifespan, and its clinical symptoms. We also calculated whether childhood trauma could predict the relationship with different clinical variables. Eighty-eight females underwent an interview to assess sociodemographic data, psychiatric comorbidities, level of pain, FM impact, clinical symptoms of anxiety, depression, insomnia, quality of life, and psychological trauma. The majority of participants (71.5%) met the diagnostic criteria for current post-traumatic stress disorder (PTSD). Participants reported having suffered traumatic events throughout their lifespan, especially in childhood and early adolescence, in the form of emotional abuse, emotional neglect, sexual abuse, and physical abuse. Traumatic events predict both poor quality of life and a level of pain in adulthood. All patients showed clinically relevant levels of anxiety, depression, insomnia, suicidal thoughts, and pain, as well as somatic comorbidities and poor quality of life. Pain levels predicted anxiety, depression, dissociation, and insomnia symptoms. 84% of the sample suffered one or more traumatic events prior to the onset of pain. Our data highlight the clinical complexity of patients with FM and the role of childhood trauma in the onset and maintenance of FM, as well as the high comorbidity between anxiety, depression, somatic symptoms, and FM. Our data also supports FM patients experiencing further retraumatization as they age, with an extremely high prevalence of current PTSD in our sample. These findings underscore the need for multidisciplinary programs for FM patients to address their physical pain and their psychiatric and somatic conditions, pay special attention to the assessment of psychological trauma, and provide trauma-focused interventions. Trial registration : ClinicalTrials.gov . Registered on July 20th, 2020.